EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Oramed Pharmaceuticals Inc. (ORMP) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$13.29M |
|
-- |
|
-- |
|
$2.49M |
|
$-2.49M |
|
$15.62M |
|
$13.13M |
|
$13.13M |
|
$13.26M |
|
$13.26M |
|
$13.26M |
|
$13.26M |
|
$-2.49M |
|
$-2.46M |
|
41.74M |
|
42.61M |
|
$0.32 |
|
$0.31 |
|
| Balance Sheet Financials | |
$99.03M |
|
$0.65M |
|
$62.66M |
|
$161.68M |
|
$3.69M |
|
-- |
|
$4.41M |
|
$8.10M |
|
$153.58M |
|
$153.58M |
|
$153.58M |
|
40.84M |
|
| Cash Flow Statement Financials | |
$-7.05M |
|
$-31.24M |
|
$-0.37M |
|
$54.42M |
|
$15.80M |
|
$-38.62M |
|
$2.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-7.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
8.63% |
|
8.63% |
|
8.20% |
|
8.63% |
|
$3.76 |
|
$-0.17 |
|
$-0.17 |
|